Sei Investments Co. Buys 23,841 Shares of OrthoPediatrics Corp. (NASDAQ:KIDS)

Sei Investments Co. raised its position in shares of OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) by 345.2% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 30,747 shares of the company's stock after acquiring an additional 23,841 shares during the period. Sei Investments Co. owned approximately 0.13% of OrthoPediatrics worth $884,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Commonwealth Equity Services LLC increased its stake in OrthoPediatrics by 0.6% during the second quarter. Commonwealth Equity Services LLC now owns 72,935 shares of the company's stock worth $2,098,000 after acquiring an additional 420 shares during the last quarter. Triodos Investment Management BV lifted its position in OrthoPediatrics by 1.2% in the second quarter. Triodos Investment Management BV now owns 41,500 shares of the company's stock worth $1,194,000 after buying an additional 500 shares during the last quarter. EntryPoint Capital LLC lifted its position in OrthoPediatrics by 56.9% in the first quarter. EntryPoint Capital LLC now owns 2,783 shares of the company's stock worth $81,000 after buying an additional 1,009 shares during the last quarter. Quest Partners LLC purchased a new position in OrthoPediatrics during the second quarter worth $34,000. Finally, SG Americas Securities LLC bought a new position in OrthoPediatrics during the second quarter valued at $110,000. 69.05% of the stock is currently owned by institutional investors.

OrthoPediatrics Trading Down 0.8 %

Shares of NASDAQ KIDS traded down $0.20 during mid-day trading on Tuesday, reaching $24.50. The company had a trading volume of 123,804 shares, compared to its average volume of 168,799. The stock has a market cap of $583.81 million, a price-to-earnings ratio of -25.52 and a beta of 1.17. OrthoPediatrics Corp. has a 52 week low of $23.10 and a 52 week high of $36.23. The business's 50-day moving average is $29.02 and its 200-day moving average is $30.20. The company has a current ratio of 4.90, a quick ratio of 1.96 and a debt-to-equity ratio of 0.03.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last issued its earnings results on Monday, August 5th. The company reported ($0.23) EPS for the quarter, topping analysts' consensus estimates of ($0.31) by $0.08. The business had revenue of $52.80 million for the quarter, compared to analyst estimates of $52.40 million. OrthoPediatrics had a negative net margin of 14.35% and a negative return on equity of 5.44%. Equities analysts expect that OrthoPediatrics Corp. will post -0.92 earnings per share for the current year.

Insider Buying and Selling at OrthoPediatrics

In other news, General Counsel Daniel J. Gerritzen sold 10,000 shares of the stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $29.30, for a total transaction of $293,000.00. Following the transaction, the general counsel now owns 77,304 shares of the company's stock, valued at approximately $2,265,007.20. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 31.80% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of equities analysts recently commented on the stock. Truist Financial reaffirmed a "hold" rating and set a $34.00 price target (up from $30.00) on shares of OrthoPediatrics in a research note on Friday, September 13th. Needham & Company LLC restated a "buy" rating and set a $42.00 target price on shares of OrthoPediatrics in a research report on Friday, September 13th. Finally, JMP Securities reaffirmed a "market outperform" rating and set a $50.00 target price on shares of OrthoPediatrics in a research note on Friday, September 13th.

OrthoPediatrics Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.